Jun. 5 at 8:05 PM
$KALV Equity Corporate Actions Alert #2026 - 390
Information Regarding the Merger of KalVista Pharmaceuticals, Inc. (KALV)
https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-390
The tender offer by Skyline Merger Sub, Inc. a wholly owned subsidiary of Chiesi Farmaceutici S.p.A. to acquire all of the outstanding common stock of KalVista Pharmaceuticals, Inc. (KALV) is scheduled to expire one minute after 11:59 p.m. ET, on June 10, 2026, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on June 11, 2026. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on June 10, 2026. If the merger closes as planned, the stock will remain halted on the day of closing (June 11th) and will be suspended effective June 12, 2026.
